Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment

Autor: Gunnar Juliusson, Alexander Schmitz, Christian H. Geisler, G W Jürgensen, Per Hörnsten, Gunnar Kvalheim, Kari Remes, Stein Kvaløy, Martin Boegsted, O J Bergmann, Lars Møller Pedersen, Hans Erik Johnsen, Eeva Juvonen

Publikováno v: Johnsen, H E, Geisler, C, Juvonen, E, Remes, K, Juliusson, G, Hörnsten, P, Kvaloy, S, Kvalheim, G, Jürgensen, G W, Pedersen, L M, Bergmann, O J, Schmitz, A & Boegsted, M 2011, ' Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment ', Bone Marrow Transplantation, vol. 46, no. 1, pp. 44-51 . https://doi.org/10.1038/bmt.2010.84
Johnsen, H E, Geisler, C, Juvonen, E, Remes, K, Juliusson, G, Hörnsten, P, Kvaloy, S, Kvalheim, G, Jürgensen, G W, Pedersen, L M, Bergmann, O J, Schmitz, A & Bøgsted, M 2011, ' Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment ', Bone Marrow Transplantation, vol. 46, no. 1, pp. 44-51 . https://doi.org/10.1038/bmt.2010.84

Udgivelsesdato: 2010-May-3 SCF has been shown to synergize with G-CSF to mobilize CD34(+) PBPCs. In this study we report results from this combination after a phase II trial of 32 patients with malignant lymphoma randomized to receive recombinant met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53b92cb61b55b0f1a15775eb0859e60
https://doi.org/10.1038/bmt.2010.84